De Braud F - Search Results

1

Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cells.

Lucibello M, Adanti S, Antelmi E, Dezi D, Ciafrè S, Carcangiu ML, Zonfrillo M, Nicotera G, Sica L, De Braud F, Pierimarchi P. Lucibello M, et al. Among authors: de braud f. Oncotarget. 2015 Mar 10;6(7):5275-91. doi: 10.18632/oncotarget.2971. Oncotarget. 2015. PMID: 25779659 Free PMC article.

2

¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study.

Crippa F, Agresti R, Sandri M, Mariani G, Padovano B, Alessi A, Bianchi G, Bombardieri E, Maugeri I, Rampa M, Carcangiu ML, Trecate G, Pascali C, Bogni A, Martelli G, de Braud F. Crippa F, et al. Among authors: de braud f. Eur J Nucl Med Mol Imaging. 2015 May;42(6):818-30. doi: 10.1007/s00259-015-2995-8. Epub 2015 Feb 12. Eur J Nucl Med Mol Imaging. 2015. PMID: 25673053

3

A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification.

Dugo M, Nicolini G, Tragni G, Bersani I, Tomassetti A, Colonna V, Del Vecchio M, De Braud F, Canevari S, Anichini A, Sensi M. Dugo M, et al. Among authors: de braud f. Oncotarget. 2015 Mar 10;6(7):5118-33. doi: 10.18632/oncotarget.3007. Oncotarget. 2015. PMID: 25742786 Free PMC article.

4

Better Together: Targeted Combination Therapies in Breast Cancer.

Zanardi E, Bregni G, de Braud F, Di Cosimo S. Zanardi E, et al. Among authors: de braud f. Semin Oncol. 2015 Dec;42(6):887-95. doi: 10.1053/j.seminoncol.2015.09.029. Epub 2015 Sep 24. Semin Oncol. 2015. PMID: 26615133 Review.

5

Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade.

Penna I, Molla A, Grazia G, Cleris L, Nicolini G, Perrone F, Picciani B, Del Vecchio M, de Braud F, Mortarini R, Anichini A. Penna I, et al. Among authors: de braud f. Oncotarget. 2016 Jan 26;7(4):3947-65. doi: 10.18632/oncotarget.6600. Oncotarget. 2016. PMID: 26678033 Free PMC article.

6

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b.

Vergani E, Di Guardo L, Dugo M, Rigoletto S, Tragni G, Ruggeri R, Perrone F, Tamborini E, Gloghini A, Arienti F, Vergani B, Deho P, De Cecco L, Vallacchi V, Frati P, Shahaj E, Villa A, Santinami M, De Braud F, Rivoltini L, Rodolfo M. Vergani E, et al. Among authors: de cecco l, de braud f. Oncotarget. 2016 Jan 26;7(4):4428-41. doi: 10.18632/oncotarget.6599. Oncotarget. 2016. PMID: 26684239 Free PMC article.

7

How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies.

Pusceddu S, De Braud F, Lo Russo G, Concas L, Femia D, Vernieri C, Indini A, Formisano B, Buzzoni R. Pusceddu S, et al. Among authors: de braud f. Oncotarget. 2016 Jul 12;7(28):44841-44847. doi: 10.18632/oncotarget.8601. Oncotarget. 2016. PMID: 27057638 Free PMC article. Review.

8

miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer.

D'Ippolito E, Plantamura I, Bongiovanni L, Casalini P, Baroni S, Piovan C, Orlandi R, Gualeni AV, Gloghini A, Rossini A, Cresta S, Tessari A, De Braud F, Di Leva G, Tripodo C, Iorio MV. D'Ippolito E, et al. Among authors: de braud f. Cancer Res. 2016 Sep 15;76(18):5562-72. doi: 10.1158/0008-5472.CAN-16-0140. Epub 2016 Jul 11. Cancer Res. 2016. PMID: 27402080

9

Complete remission in metastatic breast cancer: expecting the unexpected-results of a cross-sectional study.

Galli G, Tessari A, Porcu L, Bregni G, Paolini B, Carcangiu ML, Gennaro M, De Santis MC, Lozza L, de Braud F, Di Cosimo S. Galli G, et al. Among authors: de santis mc, de braud f. Breast Cancer. 2017 Jul;24(4):635-641. doi: 10.1007/s12282-017-0751-6. Epub 2017 Jan 5. Breast Cancer. 2017. PMID: 28058615

10

Evaluation of Local Oncologic Safety in Nipple-Areola Complex-sparing Mastectomy After Primary Chemotherapy: A Propensity Score-matched Study.

Agresti R, Sandri M, Gennaro M, Bianchi G, Maugeri I, Rampa M, Capri G, Carcangiu ML, Trecate G, Riggio E, Lozza L, de Braud F. Agresti R, et al. Among authors: de braud f. Clin Breast Cancer. 2017 Jun;17(3):219-231. doi: 10.1016/j.clbc.2016.12.003. Epub 2016 Dec 24. Clin Breast Cancer. 2017. PMID: 28087389

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

673 results

Search Page